# The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.

> **NCT06765850** · — · RECRUITING · sponsor: **Technische Universität Dresden** · enrollment: 3000 (estimated)

## Conditions studied

- Melanoma of Skin

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06765850
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06765850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06765850, "The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06765850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*